Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI

Single Dose Gadobutrol in Comparison to Single Dose Gadobenate Dimeglumine for Magnetic Resonance Imaging of Chronic Myocardial Infarction at 3 Tesla

This study aims at evaluating the diagnostic efficacy of Gadobutrol versus Gadobenate dimeglumine at similar dose of 0.1mmol/kg for assessment of myocardial infarction by delayed enhancement cardiac Magnetic Resonance Imaging

Inclusion Criteria:

• Diagnosis of myocardial infarction
• Age ≥ 18 years and ≤ 80 years
• Informed consent
• Male patients as well as female patients using contraceptives

Exclusion Criteria:

• Patients with a heart pacemaker, with magnetic material or other magnetic implants.
• Renal failure (GFR <30ml/min)
• Patients with known allergy to a Gadolinium-containing contrast agent
• Drugs or alcohol addiction, dementia